Rate of Adriamycin Resistance Associated (ARA) long Noncoding RNA Expression in Sample of Hepatitis B Virus Iraqi Patients
DOI:
https://doi.org/10.32947/ajps.v24i4.1087Keywords:
HBV, LncRNA, PCR, ARA LncRNAAbstract
Numerous biological processes, including epigenetics regulation, control of cell cycle, beside transcriptional, translational and regulation of genes expression, have been linked to long non-coding RNAs lncRNAs . the disruption of expression for lncRNAs are important early stages in in hepatitis B virus disease.
Objectives: In order to investigate ARA lncRNA production in Hepatitis B patients, analyze its clinical importance, and examine the possible value as a predictive biomarker, Amplification of Adriamycin Resistance Associated Lnc-RNA and Glyceraldehyde 3-phosphate dehydrogenase (reference gene) was done by two steps reverase- transcriptase polymerase chain reaction ,No significant difference P = 0.566 was observed in the Adriamycin Resistance Associated lncRNA serum levels between chronic hepatitis B virus patient and control ,In the patients group with chronic HBV )infection, the expression of Adriamycin Resistance Associated lncRNAs was elevated to the 2 fold.
References
- Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral research. 2020; 182:104925. DOI: https://doi.org/10.1016/j.antiviral.2020.104925
- al-Tamimi AA.Prevalence of Hepatitis B virus infection in al-Taji district. Al- Mustansiriyah J. Sci. 2013;24(2):25–30.
- Maral F T, Mohammed H. A, Nazar M A, Knowledge About Hepatitis B Infection Among Undergraduate Medical and Health College Students, Baghdad. Mustansiriya Medical Journal201. 2017;16(2):63–67. DOI: https://doi.org/10.4103/2070-1128.251020
- Samulin Erdem J, Notø H, Skare. Mechanisms of breast cancer risk in shift workers: association of telomere short-ening with the duration and intensity of night work. Cancer Med. 2017; 6:1988–1997. DOI: https://doi.org/10.1002/cam4.1135
- Gibb EA. Brown CJ. Lam WL. The functional role of long non-cod-ing RNA in human carcinomas. Mol Cancer. 2011; 10:38. DOI: https://doi.org/10.1186/1476-4598-10-38
- Agliano F, Rathinam VA, Medvedev AE, Vanaja SK, Vella AT. Long noncoding RNAs in host–pathogen interactions. Trends Immunol. 2019;40(6):492–510. DOI: https://doi.org/10.1016/j.it.2019.04.001
- Yilmaz Susluer S, Kayabasi C, Ozmen Yelken B. Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients. Bosn J Basic Med Sci. 2018;18(2):150–61.
- Liu Y, Feng J, Sun M, et al. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma. Cancer Lett. 2019; 454:158–70. DOI: https://doi.org/10.1016/j.canlet.2019.04.008
- Malhotra A, Jain M, Prakash H, et al. The regulatory roles of long non-coding RNAs in the development of chemoresist-ance in breast cancer. Oncotarget . 2017; 8:110671–110684. DOI: https://doi.org/10.18632/oncotarget.22577
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2–∆∆CT method. Methods. 2001; 25:402–408. DOI: https://doi.org/10.1006/meth.2001.1262
- Kadham, M. Precore and Basal Core Promoter mutations of chronic Hepatitis B virus in relation to drug resistance chronic infections in some Iraqi. 2018. Ph.D. Thesis, College of Science. University of Mustansiriyai.
- Mak LY, Seto WK, Fung J, Yuen MF. Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B. Hepatology International. 2020; 14:35-46. DOI: https://doi.org/10.1007/s12072-019-09998-5
- Chan H.L., Tse C.H., Mo F., Koh J., Wong V.W., Wong G.L., et al. 2008.High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.J Clin Oncol, 26 . pp. 177-182. DOI: https://doi.org/10.1200/JCO.2007.13.2043
- Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Lu S.N., 2006.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.JAMA, 295 . pp. 65-73. DOI: https://doi.org/10.1001/jama.295.1.65
- Kondo Y, Shinjo K, Katsushima K. Long non-coding RNAs as an epigenetic regulator in human cancers. Cancer Sci .2017;108:1927–1933. DOI: https://doi.org/10.1111/cas.13342
- Farzaneh R, Mahdieh A, Raheleh A, Sara I, Esmat N, Arvand A,Esmaeil M, Mansoor K,Asghar A.ARA lncRNA, is upregulated in liver and breast tumor tissues, Molecular Biology Reports . 2018; 11033-018-4447-6
- Sunde Y, Cagla K, Besra O, Aycan A, Didem C, Tugce B, Suheyla S, Cigir B, Sukran K, Cumhur G.Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients Bosn J Basic Med Sci. 2018;18(2):150-161. DOI: https://doi.org/10.17305/bjbms.2018.2800
- Jiang, Min. "A novel long non-coding RNA-ARA: adriamycin resistance associated." Biochemical pharmacology. 2014; 87.2. 254-283. DOI: https://doi.org/10.1016/j.bcp.2013.10.020
- M.B. Melixetian. Altered expression of DNA-topoisomerase IIalpha is associated with increased rate of spontaneous polyploidization in etoposide resistant K562 cells. Leukemia Research.2000; 24(10): 831-83 DOI: https://doi.org/10.1016/S0145-2126(00)00054-0
- F. Wang. A non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Letters. 2008; 582(13):1919-1927 DOI: https://doi.org/10.1016/j.febslet.2008.05.012
- Ramnarine VR, Kobelev M, Gibb EA. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management. Eur Urol. 2019;76(5):546–59. DOI: https://doi.org/10.1016/j.eururo.2019.07.040
- Zhang L, Meng X, Zhu XW. Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications. Mol Cancer .2019;18(1):102. DOI: https://doi.org/10.1186/s12943-019-1021-3
- Li C, Chen J, Zhang K, Feng B, Wang R, Chen L. Progress and prospects of long noncoding RNAs (lncRNAs) in hepatocellular carcinoma. Cellular Physiology and Biochemistry. 2015;36(2):423-34. DOI: https://doi.org/10.1159/000430109
- Unfried JP, Sangro P, Prats-Mari L, Sangro B, Fortes P. The landscape of lncRNAs in hepatocellular carcinoma: a translational perspective. Cancers. 2021 28;13(11):2651. DOI: https://doi.org/10.3390/cancers13112651
- Matin F, Jeet V, Moya L. A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer. Sci Rep. 2018;8(1):6653. DOI: https://doi.org/10.1038/s41598-018-24424-w
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Osama Mohammed Hasan
This work is licensed under a Creative Commons Attribution 4.0 International License.